Literature DB >> 24374135

Long-term exposure to low-concentrations of Cr(VI) induce DNA damage and disrupt the transcriptional response to benzo[a]pyrene.

Jerald L Ovesen1, Yunxia Fan1, Jing Chen1, Mario Medvedovic1, Ying Xia1, Alvaro Puga2.   

Abstract

Living organisms are exposed on a daily basis to widespread mixtures of toxic compounds. Mixtures pose a major problem in the assessment of health effects because they often generate substance-specific effects that cannot be attributed to a single mechanism. Two compounds often found together in the environment are the heavy metal chromium and the polycyclic aromatic hydrocarbon benzo[a]pyrene (B[a]P). We have examined how long-term exposure to a low concentration of Cr(VI) affects the transcriptional response to B[a]P, a second toxicant with an unrelated mechanism of action. Growth of mouse hepatoma cells for 20 passages in medium with 0.1 or 0.5 μM Cr(VI) increases DNA damage and apoptosis while decreasing clonogenic ability. Treated cells also show transcriptome changes indicative of increased expression of DNA damage response and repair genes. In them, B[a]P activates cancer progression pathways, unlike in cells never exposed to Cr(VI), where B[a]P activates mostly xenobiotic metabolism pathways. Cells grown in Cr(VI) for 20 passages and then cultured for an additional 5 passages in the absence of Cr(VI) recover from some but not all the chromium effects. They show B[a]P-dependent transcriptome changes strongly weighted toward xenobiotic metabolism, similar to those in B[a]P-treated cells that had no previous Cr(VI) exposure, but retain a high level of Cr(VI)-induced DNA damage and silence the expression of DNA damage and cancer progression genes. We conclude that the combined effect of these two toxicants appears to be neither synergistic nor additive, generating a toxic/adaptive condition that cannot be predicted from the effect of each toxicant alone.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  B[a]P; Chromium; Complex mixtures; Gene expression; Heavy metals; Transcriptome

Mesh:

Substances:

Year:  2013        PMID: 24374135      PMCID: PMC3945963          DOI: 10.1016/j.tox.2013.12.001

Source DB:  PubMed          Journal:  Toxicology        ISSN: 0300-483X            Impact factor:   4.221


  32 in total

Review 1.  Importance of chromium-DNA adducts in mutagenicity and toxicity of chromium(VI).

Authors:  Anatoly Zhitkovich
Journal:  Chem Res Toxicol       Date:  2005-01       Impact factor: 3.739

Review 2.  Cytometry of ATM activation and histone H2AX phosphorylation to estimate extent of DNA damage induced by exogenous agents.

Authors:  Toshiki Tanaka; Xuan Huang; H Dorota Halicka; Hong Zhao; Frank Traganos; Anthony P Albino; Wei Dai; Zbigniew Darzynkiewicz
Journal:  Cytometry A       Date:  2007-09       Impact factor: 4.355

3.  Chemical mixtures from a public health perspective: the importance of research for informed decision making.

Authors:  K Sexton; B D Beck; E Bingham; J D Brain; D M DeMarini; R C Hertzberg; E J O'Flaherty; J G Pounds
Journal:  Toxicology       Date:  1995-12-28       Impact factor: 4.221

Review 4.  Studies on the metabolism of benzo[a]pyrene and dose-dependent differences in the mutagenic profile of its ultimate carcinogenic metabolite.

Authors:  A H Conney; R L Chang; D M Jerina; S J Wei
Journal:  Drug Metab Rev       Date:  1994       Impact factor: 4.518

5.  Preferential formation and repair of chromium-induced DNA adducts and DNA--protein crosslinks in nuclear matrix DNA.

Authors:  J Xu; F C Manning; S R Patierno
Journal:  Carcinogenesis       Date:  1994-07       Impact factor: 4.944

Review 6.  Human AH locus polymorphism and cancer: inducibility of CYP1A1 and other genes by combustion products and dioxin.

Authors:  D W Nebert; D D Petersen; A Puga
Journal:  Pharmacogenetics       Date:  1991-11

Review 7.  Potency equivalency factors for some polycyclic aromatic hydrocarbons and polycyclic aromatic hydrocarbon derivatives.

Authors:  J F Collins; J P Brown; G V Alexeeff; A G Salmon
Journal:  Regul Toxicol Pharmacol       Date:  1998-08       Impact factor: 3.271

8.  Use of toxic equivalency factors for risk assessment for dioxins and related compounds.

Authors:  L S Birnbaum; M J DeVito
Journal:  Toxicology       Date:  1995-12-28       Impact factor: 4.221

9.  Chromium cross-links histone deacetylase 1-DNA methyltransferase 1 complexes to chromatin, inhibiting histone-remodeling marks critical for transcriptional activation.

Authors:  Michael Schnekenburger; Glenn Talaska; Alvaro Puga
Journal:  Mol Cell Biol       Date:  2007-08-06       Impact factor: 4.272

10.  Identification of the Ah receptor nuclear translocator protein (Arnt) as a component of the DNA binding form of the Ah receptor.

Authors:  H Reyes; S Reisz-Porszasz; O Hankinson
Journal:  Science       Date:  1992-05-22       Impact factor: 47.728

View more
  11 in total

Review 1.  Chromium exposure disrupts chromatin architecture upsetting the mechanisms that regulate transcription.

Authors:  Hesbon A Zablon; Andrew VonHandorf; Alvaro Puga
Journal:  Exp Biol Med (Maywood)       Date:  2019-04-01

2.  Long-term Coexposure to Hexavalent Chromium and B[a]P Causes Tissue-Specific Differential Biological Effects in Liver and Gastrointestinal Tract of Mice.

Authors:  Francisco Javier Sánchez-Martín; Yunxia Fan; Vinicius Carreira; Jerald L Ovesen; Andrew Vonhandorf; Ying Xia; Alvaro Puga
Journal:  Toxicol Sci       Date:  2015-03-29       Impact factor: 4.849

3.  Chromium disrupts chromatin organization and CTCF access to its cognate sites in promoters of differentially expressed genes.

Authors:  Andrew VonHandorf; Francisco Javier Sánchez-Martín; Jacek Biesiada; Hongxia Zhang; Xiang Zhang; Mario Medvedovic; Alvaro Puga
Journal:  Epigenetics       Date:  2018-05-03       Impact factor: 4.528

4.  Hexavalent chromium increases the metabolism and genotoxicity of aromatic amine carcinogens 4-aminobiphenyl and β-naphthylamine in immortalized human lung epithelial cells.

Authors:  James T F Wise; Raúl A Salazar-González; Kennedy M Walls; Mark A Doll; Mariam R Habil; David W Hein
Journal:  Toxicol Appl Pharmacol       Date:  2022-06-02       Impact factor: 4.460

5.  A visual and reversible nanoprobe for rapid and on-site determination of hexavalent chromium and lysine based on dual-emission carbon quantum dots coupled with smartphone.

Authors:  Chi-Xuan Yao; Lu Yang; Jin Wang; Huan Lv; Xue-Meng Ji; Shi-Jie Li; Jing-Min Liu; Shuo Wang
Journal:  Mikrochim Acta       Date:  2022-08-29       Impact factor: 6.408

6.  Upregulation of histone-lysine methyltransferases plays a causal role in hexavalent chromium-induced cancer stem cell-like property and cell transformation.

Authors:  Zhishan Wang; Jianjun Wu; Brock Humphries; Kazuya Kondo; Yiguo Jiang; Xianglin Shi; Chengfeng Yang
Journal:  Toxicol Appl Pharmacol       Date:  2018-01-31       Impact factor: 4.219

7.  Hexavalent chromium promotes differential binding of CTCF to its cognate sites in Euchromatin.

Authors:  Andrew VonHandorf; Hesbon A Zablon; Jacek Biesiada; Xiang Zhang; Mario Medvedovic; Alvaro Puga
Journal:  Epigenetics       Date:  2021-01-07       Impact factor: 4.528

8.  Formaldehyde-Assisted Isolation of Regulatory Elements (FAIRE) analysis uncovers broad changes in chromatin structure resulting from hexavalent chromium exposure.

Authors:  Jerald L Ovesen; Yunxia Fan; Xiang Zhang; Jing Chen; Mario Medvedovic; Ying Xia; Alvaro Puga
Journal:  PLoS One       Date:  2014-05-16       Impact factor: 3.240

9.  Gene 33/Mig6 inhibits hexavalent chromium-induced DNA damage and cell transformation in human lung epithelial cells.

Authors:  Soyoung Park; Cen Li; Hong Zhao; Zbigniew Darzynkiewicz; Dazhong Xu
Journal:  Oncotarget       Date:  2016-02-23

Review 10.  Hexavalent chromium disrupts chromatin architecture.

Authors:  Andrew VonHandorf; Hesbon A Zablon; Alvaro Puga
Journal:  Semin Cancer Biol       Date:  2021-07-15       Impact factor: 15.707

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.